Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines

Figure 2

Proportion of subjects according to KDIGO 2009 risk categories. Mild (group 9-14): stages 1A2, 2A2, 3aA1; Moderate (group 15-21) stages 1A3, 2A3, 3aA2, 3bA1; Severe (group ≥ 22): stages 3aA3, 3bA2-3, All 4 and 5. Data expressed as percentages of all subjects (n = 5526). CKD-EPI. CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration; S-MDRD, standard MDRD; C-MDRD, Chinese MDRD, J-EPI Japanese CKD-EPI, T-GFR Thai GFR.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us